Up to 50% of cases of suspected LS in patients with CRC that test positive for MMR-D by IHC or MSI do not have any germline mutation in an MMR gene, BRAF alteration or MLH1 hypermethylation [1]. This evidence concerns the gene MLH1 and colorectal carcinoma.